U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.3137T>C (p.Leu1046Pro) AND Ataxia-telangiectasia syndrome

Germline classification:
Conflicting classifications of pathogenicity (4 submissions)
Last evaluated:
Jan 18, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000667954.15

Allele description [Variation Report for NM_000051.4(ATM):c.3137T>C (p.Leu1046Pro)]

NM_000051.4(ATM):c.3137T>C (p.Leu1046Pro)

Gene:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.3137T>C (p.Leu1046Pro)
Other names:
NM_000051.3(ATM):c.3137T>C
HGVS:
  • NC_000011.10:g.108272591T>C
  • NG_009830.1:g.54760T>C
  • NM_000051.4:c.3137T>CMANE SELECT
  • NM_001351834.2:c.3137T>C
  • NP_000042.3:p.Leu1046Pro
  • NP_000042.3:p.Leu1046Pro
  • NP_001338763.1:p.Leu1046Pro
  • LRG_135t1:c.3137T>C
  • LRG_135:g.54760T>C
  • LRG_135p1:p.Leu1046Pro
  • NC_000011.9:g.108143318T>C
  • NC_000011.9:g.108143318T>C
  • NM_000051.3:c.3137T>C
  • Q13315:p.Leu1046Pro
  • p.L1046P
Protein change:
L1046P
Links:
UniProtKB: Q13315#VAR_077237; dbSNP: rs568461905
NCBI 1000 Genomes Browser:
rs568461905
Molecular consequence:
  • NM_000051.4:c.3137T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351834.2:c.3137T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Ataxia-telangiectasia syndrome (AT)
Synonyms:
Louis-Bar syndrome; Cerebello-oculocutaneous telangiectasia; Immunodeficiency with ataxia telangiectasia; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008840; MedGen: C0004135; Orphanet: 100; OMIM: 208900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000792486Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Uncertain significance
(Jun 26, 2017)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV000823337Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 18, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV001452063Natera, Inc.
no assertion criteria provided
Uncertain significance
(Sep 16, 2020)
germlineclinical testing

SCV002097335Suma Genomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicinheritedclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedinheritedyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular and Functional Characterization of a Cohort of Spanish Patients with Ataxia-Telangiectasia.

Carranza D, Vega AK, Torres-Rusillo S, Montero E, Martinez LJ, SantamarĂ­a M, Santos JL, Molina IJ.

Neuromolecular Med. 2017 Mar;19(1):161-174. doi: 10.1007/s12017-016-8440-8. Epub 2016 Sep 23.

PubMed [citation]
PMID:
27664052

Clinical spectrum of ataxia-telangiectasia in adulthood.

Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, Hiel JA, Brunt ER, van Rijn MA, Majoor Krakauer D, Oldenburg RA, Broeks A, Last JI, van't Veer LJ, Tijssen MA, Dubois AM, Kremer HP, Weemaes CM, Taylor AM, van Deuren M.

Neurology. 2009 Aug 11;73(6):430-7. doi: 10.1212/WNL.0b013e3181af33bd. Epub 2009 Jun 17.

PubMed [citation]
PMID:
19535770
See all PubMed Citations (4)

Details of each submission

From Counsyl, SCV000792486.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000823337.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 1046 of the ATM protein (p.Leu1046Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of ataxia-telangiectasia (PMID: 27664052; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 186558). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Studies have shown that this missense change alters ATM gene expression (PMID: 27664052). This variant disrupts the p.Leu1046 amino acid residue in ATM. Other variant(s) that disrupt this residue have been observed in individuals with ATM-related conditions (PMID: 19535770), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV001452063.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Suma Genomics, SCV002097335.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 19, 2025